Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
Clinical trial NCT02519777 · COMPLETED
Trial details
- NCT number
- NCT02519777
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-21
- Primary completion
- 2019-12-02
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.